mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.6 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.6 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.6 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.6 |